Emily Day

Membrane-modified lipid nanoparticles for RNA delivery Day and colleagues summarize progress in developing cell membrane-modified lipid nanoparticles (LNPs) for ribonucleic acid (RNA) delivery, which have improved immune evasion and targeting compared to ...

Our review "Membrane-modified lipid nanoparticles for RNA delivery" is now out in Molecular Therapy Methods & Clinical Development! www.cell.com/molecular-th...

Congratulations to Dr. Sara Aboeleneen on your doctoral hooding! From all of us in @thedaylab.bsky.social and @udbme.bsky.social.

Today I had the honor of hooding Dr. Eric Sterin. Congratulations from everyone in @udbme.bsky.social and @thedaylab.bsky.social!

I'm honored to share that I am being promoted to Professor. This milestone represents years of dedication to conducting impactful research, teaching, and service. Thank you to my mentors, mentees, students, colleagues, and family who have been part of this journey. I am excited for what's ahead!

Congratulations to Dr. Sara Aboeleneen, who today became the 10th Ph.D. graduate of @thedaylab.bsky.social! Fantastic dissertation presentation!

Congratulations to Dr. Eric Sterin, who successfully defended his thesis yesterday to become the 9th Ph.D. graduate of @thedaylab.bsky.social! Eric’s dissertation was “Evaluating and Enhancing the Immune Evasion Properties of Membrane-Wrapped Nanoparticles.”

Just 45 days left until the Cancer Nanotechnology Gordon Research Conference! Looking forward to a fantastic meeting! It has been a pleasure to organize with my co-chair @danielheller.bsky.social! www.grc.org/cancer-nanot...

Merck signs 20-year lease in Delaware following $30M state incentive Merck signed a 20-year lease for a property just outside of Wilmington, a month after Delaware enticed the company with a $30 million grant.

Exciting development! Merck plans to expand its business in Delaware! spotlightdelaware.org/2025/04/25/m...

I’m delighted to serve on the board and support the growth of RSC Pharmaceutics!

Standard purification methods are not sufficient to remove micellular lipophilic dye from polymer nanoparticle solution Tracking nanoparticles’ location is imperative for understanding cellular interactions, pharmacokinetics, and biodistribution. DiD is a lipophilic dye commonly used to label nanoparticles for traffick...

New @thedaylab.bsky.social research now published in RSC Pharmaceutics! Important insights for those who use lipophilic dyes to label nanoparticles for cellular uptake and biodistribution studies. pubs.rsc.org/en/content/a...

Way to go @udbme.bsky.social! Our students are awesome #Hengineers!

My department @udbme.bsky.social is searching for a new undergraduate academic advisor! Please spread the word!

RSC Poster: a global online poster conference #RSCPoster is a global poster conference that brings the chemistry community together online over the course of 24 hours

Great opportunity to share your research and hear about the latest advancements! www.rsc.org/our-events/r...

The NIH’s drastic cut to indirect cost rates is a critical threat to U.S. research infrastructure The drastic reduction in indirect costs is not a path to innovation or cost savings — it’s a threat to U.S.’s position as global leader in medical research.

I am deeply concerned about the cuts to indirect cost rates on NIH grants. "These costs are not a waste or luxury — they make groundbreaking discoveries possible." This change will cause the U.S. to lose its position as a global leader in medical research. Encourage your policymakers to act now!

Looks delicious!

The Cancer Nanotechnology GRC I am co-chairing with @danielheller.bsky.social is just a few months away! Apply soon so you don’t miss this fantastic conference! Applications for the associated trainee-focused GRS are due by March 9 to be considered for a speaking opportunity.

Hello 🦋 community! I am excited to join this platform to share news from my research team and learn about my colleagues' recent developments!